BUDAPEST, Hungary--(BUSINESS WIRE)--Albany Molecular Research, Inc. (NASDAQ: AMRI) announced today the launch of the CancerGrid Project, a three-year multidisciplinary research program funded by the European Commission in which ten life sciences companies and academic centers will work together to discover and develop novel anti-cancer agents.
